Embold Therapeutics, Inc.
through Jul 24, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 9, 2026 · D | Jul 24, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $3,000,000 | $4,975,000 | $1,975,000 |
| Reported amount sold | $130,000 | $2,470,587 | $2,340,587 |
| Reported investor count | — | 7 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002109643-26-000002 · Later SEC source: 0002109643-26-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $4,975,000
- Reported amount sold
- $2,470,587
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (3)
-
0002109643-26-000003D/A · Jul 24, 2026 · BiotechnologyOffering: $4,975,000Sold: $2,470,587
-
0002109643-26-000002D · Feb 9, 2026 · BiotechnologyOffering: $3,000,000Sold: $130,000
-
0002109643-26-000001D · Feb 9, 2026 · BiotechnologyOffering: $500,000Sold: $500,000